Search | Médecins Sans Frontières Access Campaign

2896 results found
There are 0 active filters

2896 results found

Newsletter |

12 September 2023

Join the Time for $5 campaign to save millions of lives

Today we hit the road running with our campaign, ‘Time for $5’, calling on the US company Cepheid, and its parent corporation Danaher, to drop the price of a lifesaving test, GeneXpert, to save millions of people’s lives around the world.

Research article |

11 September 2023

The Lancet Child & Adolescent Health: Reversing the neglect of children and adolescents affected by tuberculosis

MSF and co-authors call for commitments from countries at the UNHLM on TB to address gaps in TB care for children and adolescents.

Tags Tuberculosis tuberculosis

07 September 2023

Campaign Newsletter

Tags tuberculosis Time for $5

A clinician gathering antiretroviral medications for a patient at Maram Dispensary in Ndhiwa sub county, Homa Bay County, Kenya, 2021

Press release |

17 August 2023

MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA

MSF urges ViiV to withdraw problematic purchasing conditions hindering access to HIV prevention drug CAB-LA

Tags HIV/AIDS HIV/AIDS cabotegravir ViiV

Mr and Ms Kimboi, both of whom are living with HIV, picking up their medicines at the MSF Chakpikarong clinic, Thailand, 2019

Letter |

17 August 2023

Open letter to ViiV to improve access to HIV prevention drug CAB-LA

MSF letter to ViiV asking the company to withdraw problematic purchasing conditions for HIV prevention drug CAB-LA

Tags HIV/AIDS HIV/AIDS cabotegravir ViiV

Video |

17 August 2023

Testimonies for access to HIV prevention drug CAB-LA

CAB-LA is a game-changing HIV prevention medicine, but access to it is currently a challenge.

Tags HIV/AIDS HIV/AIDS cabotegravir

Moussa, type I diabetes patient, in MSF project in Arsal, Lebanon.

Feature story |

07 August 2023

Moussa's story: Access to insulin pens in humanitarian settings

How insulin pens simplify lives for children living with Type 1 diabetes.

Tags Diabetes Diabetes Insulin

Letter |

31 July 2023

Open letter: Requesting clarification from J&J on the recent deal for generic bedaquiline supply

Open letter by CSOs to US pharma J&J seeking clarification on the deal for supply of generic versions of TB bedaquiline

Tags Tuberculosis drug-resistant TBtuberculosis bedaquiline Johnson & Johnson

MSF medical staff administers measles vaccinations to children in Ndjala village, Drodro Ituri province, Democratic Republic of Congo, May 2023

Press release |

18 July 2023

Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery

MSF again called on Gavi to broaden catch-up vaccine coverage for children by waiving co-financing requirements of countries with fragile health systems

Tags Vaccines Gavi, the Vaccine Alliance

Bottle of bedaquiline, Zhytomyr Regional TB Dispensary, Ukraine. In 2018, MSF started providing treatment for drug-resistant TB to people in Zhytomyr, Ukraine.

Press release |

17 July 2023

MSF calls for commitment from pharma corporation J&J to not enforce extended patents on lifesaving TB drug as main patent expires in India, opening door to affordable generics

MSF calls on Johnson & Johnson not to enforce its secondary patents on TB drug bedaquiline

Tags Tuberculosis tuberculosis bedaquiline Johnson & Johnson

Technical brief |

17 July 2023

MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies

Principles and actions for equitable access to medical products

Tags Pandemic preparednessIntellectual property and tradeResearch and development TRIPS

Deepak, who lives with DR-TB, was treated with the TB medicine bedaquiline. Mumbai, India, 2022.

Press release |

13 July 2023

TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries

MSF calls on J&J not to enforce secondary patents on TB drug bedaquiline, to improve global access to this lifesaving medicine

Tags Intellectual property and tradeTuberculosis tuberculosis

After discovering she is HIV positive, Gisela suffered from anxiety, depression and panic attacks. Buenaventura, Colombia, 2016.

Press release |

13 July 2023

Colombia to challenge AIDS drug patents

MSF signed onto a letter supporting Colombia’s action to possibly issue a compulsory license to improve access to HIV drug dolutegravir

Tags HIV/AIDSIntellectual property and trade Colombia

Letter |

13 July 2023

CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir

MSF co-signed a CSO letter to Colombia welcoming a resolution on issuing a compulsory license for HIV drug dolutegravir

Tags HIV/AIDSIntellectual property and trade HIV/AIDS Colombia

MSF nurses giving free consultations to unaccompanied foreign minors in the Paris camp. 2020.

Press release |

12 July 2023

MSF welcomes pro-access recommendations in European Parliament COVID report

Pro-access recommendations should serve as a blueprint for the EU to ensure equitable global access to medical tools in a future pandemic

Tags COVID-19 coronavirus

Letter |

11 July 2023

Belarus: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis

Letter from national TB programme of Belarus calling on Johnson & Johnson not to enforce secondary patents on drug bedaquiline

Tags Intellectual property and tradeTuberculosis Belarus

Letter |

11 July 2023

Open Letter: Urgent action necessary for equitable access to bedaquiline in all countries with high burdens of TB, MDR-TB, and TB/HIV

MSF and other CSOs sent a letter to Johnson & Johnson, calling on the pharmaceutical corporation not to enforce its secondary patents on TB drug bedaquiline

Tags Intellectual property and tradeTuberculosis

Letter |

29 June 2023

Open Letters: Civil society calls on Abbott and BD to ensure access to HIV CD4 tests

In open letters, civil society organisations call on Abbott and BD Biosciences to ensure access to CD4 diagnostic tests critical for HIV care

Tags DiagnosticsHIV/AIDS Abbott

Child at a vaccination site for nomadic communities, N'Djamena, Chad

Press release |

12 June 2023

MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old

Gavi must do more to vaccinate children up to age five, and waive co-financing requirements of countries with fragile health systems or in humanitarian crisis

Tags Vaccines Gavi, the Vaccine Alliance

MSF's Dr Ilham checking on a patient at a hospital in Mumbai, India.

Statement |

12 June 2023

Pandemic Accord: MSF statement on INB Bureau’s text

MSF statement at the 5th Intergovernmental Negotiating Body (INB) on WHO Pandemic Accord

Tags Pandemic preparednessIntellectual property and trade TRIPS

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Join the Time for $5 campaign to save millions of lives

The Lancet Child & Adolescent Health: Reversing the neglect of children and adolescents affected by tuberculosis

Campaign Newsletter

MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA

Open letter to ViiV to improve access to HIV prevention drug CAB-LA

Testimonies for access to HIV prevention drug CAB-LA

Moussa's story: Access to insulin pens in humanitarian settings

Open letter: Requesting clarification from J&J on the recent deal for generic bedaquiline supply

Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery

MSF calls for commitment from pharma corporation J&J to not enforce extended patents on lifesaving TB drug as main patent expires in India, opening door to affordable generics

MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies

TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries

Colombia to challenge AIDS drug patents

CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir

MSF welcomes pro-access recommendations in European Parliament COVID report

Belarus: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis

Open Letter: Urgent action necessary for equitable access to bedaquiline in all countries with high burdens of TB, MDR-TB, and TB/HIV

Open Letters: Civil society calls on Abbott and BD to ensure access to HIV CD4 tests

MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old

Pandemic Accord: MSF statement on INB Bureau’s text